LIABILITY PROTECTION THROUGH TESTING
Testing is not just a quality assurance step—it is a form of legal protection. Third-party laboratory analyses create an objective record that can be presented in regulatory inquiries and court proceedings. These Certificates of Analysis (COAs) serve as evidence of due diligence, ensuring that products meet safety, potency, and purity standards. According to the Electronic Code of Federal Regulations (eCFR), public disclosure of such records, including testing data, is regulated under 21 CFR Part 20
​
By maintaining accurate, batch-specific lab reports, companies protect themselves against liability, demonstrate good manufacturing practices, and build trust with consumers and regulatory bodies alike.
Galena ensures that all products tested through its partners comply with documentation and traceability standards that can support clients in legal or regulatory scenarios, if necessary.
THE FARM BILL
The Agricultural Improvement Act of 2018, commonly known as the 2018 Farm Bill, federally legalized hemp and its derivatives—such as CBD and CBG—provided the delta-9 THC content does not exceed 0.3% on a dry weight basis. This legislative shift removed hemp from the Controlled Substances Act, allowing cultivation, production, and commerce of hemp-derived cannabinoids under USDA oversight.
To remain compliant, brands must ensure their products are derived from legally defined hemp and tested for THC content, among other safety parameters. Failure to meet these standards may result in products being considered illegal cannabis under federal law.
Galena supports companies in navigating this legal framework, providing testing services and documentation that align with Farm Bill requirements. You can consult the full text of the Farm Bill under Public Law No: 115-334 (source: https://www.congress.gov/bill/115th-congress/house-bill/2).